This feature is not available for account registered as an employer. Please login with another account.
B. Braun Vietnam is one of the country’s top healthcare companies. It was established in Vietnam in 1992 and backed up by more than 175 years of experience in continuous pioneering and innovative breakthroughs worldwide. Together with its mother company B. Braun Melsungen A.G. and 64 subsidiaries worldwide, B. Braun has been providing world-class products and services to health care professionals.
In the year 1990 B. Braun sold its first products in Vietnam via a Singapore exporter. These products consisted of IV solutions and medical disposables. It established the first Representative office in Ho Chi Minh City in 1992, followed by a representative office in Hanoi in 1993, then in Da Nang and Hue in the years after. In 1996, the construction of the first IV solutions factory was started and it was inaugurated in 1997. The factory had the first extension in 1999 and received its first GMP certificate. In 2008, the construction of the first B. Braun IV sets manufacturing plant in Hanoi, Vietnam was started. The factory was inaugurated in 2011 with the total investment of 32.6 Mio. EUR in the new IV set production facilities, making it the largest medical technology complex in Vietnam. B. Braun affirmed its commitment to invest further in Vietnam through the expansion of the current medical plant in Thanh Oai. The expansion includes a 35.5 Mio. EUR medical equipment factory of 8,500sqm, which was completed in the first quarter of 2015, raising the total investment for this plant to 71 Mio. EUR. Further expansion of the factory is planned to be in the beginning of 2017 with the additional investment of USD 100 million.
Today, B. Braun Vietnam with a strong and driven sales force and service team, is one of the leading healthcare companies offering and pioneering in quality and cutting-edge health care products such as infusion solutions and devices, IV cannula, sutures, surgical instruments, diabetes care, out patient market products, value added drugs, regional anesthesia and clinical nutrition.